An Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of BIIB067 (Tofersen) in Adults With Inherited Amyotrophic Lateral Sclerosis (ALS)
Clinical trial NCT02623699 · COMPLETED
Trial details
- NCT number
- NCT02623699
- Sponsor
- Biogen
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-20
- Primary completion
- 2021-07-16
- Enrollment
- 176
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.